Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C)

2019 ◽  
Vol 57 (4) ◽  
pp. 820-827
Author(s):  
Ren-wang Chen ◽  
Sheng-li Yang ◽  
Zhong-yu Xu ◽  
Miao Peng ◽  
Meng-ni Chen ◽  
...  
Keyword(s):  
Gastrointestinal Cancer ◽  
Chinese Version ◽  
Symptom Inventory ◽  
Cancer Module

scholarly journals Translation and Validation of M.D. Anderson Symptom Inventory-Thyroid Cancer Module in Chinese Thyroid Cancer Patients: A Cross-Sectional and Methodological Study

2022 ◽  
Author(s):  
Ziyi Hu ◽  
Juxiang Gou ◽  
Ming Cai ◽  
Yueer Zhang
Keyword(s):  
Thyroid Cancer ◽  
Cancer Patients ◽  
Symptom Management ◽  
Discriminant Validity ◽  
Chinese Version ◽  
Validity And Reliability ◽  
European Organization ◽  
Specific Symptom ◽  
Symptom Inventory ◽  
Cancer Module

Abstract Aim To translate and validate the Chinese version of the MDASI-THY among thyroid cancer patients. Background The M.D. Anderson Symptom Inventory-Thyroid Cancer module (MDASI-THY) is one of well-validated instruments for thyroid-specific symptom assessment. To date, the instrument has not been used in China. Methods After standard forward- and back-translation procedures, two instruments, the Chinese version of MDASI-THY and the European Organization for Research and Treatment of Cancer QLQ C30, were answered by 309 thyroid patients. The content, convergent discriminant validity and reliability of the MDASI-THY were evaluated. The Standards for Reporting Diagnostic Accuracy Studies (STARD) was used as reporting checklist. Results S-CVI and I-CVI of the instrument were over 0.80. There were significant relationships between MDASI-THY and EORTC QLQ-C30 (p<0.001). Symptoms were severer for patients underwent surgical treatment. The Cronbach’s alpha was 0.966 (between 0.954 and 0.827 for subscales). Most symptom items had moderate to high interitem correlations. Conclusions The Chinese version of MDASI-THY demonstrated favorable validity and reliability. It can be used in development of symptom management program in thyroid cancer patients in China. Relevance to clinical practice: Nurse can apply this instrument to assess Chinese thyroid cancer patients to increase the understanding of their symptom experience, resulting in a better symptom management.

scholarly journals Translation and validation of the Chinese version of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer

2021 ◽  
Author(s):  
Ting Zhang ◽  
Ying-ying Zheng ◽  
Zhi-rong Yang ◽  
Qiuling Shi ◽  
Xin Shelley Wang ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Symptom Severity ◽  
Assessment Tool ◽  
Gynecologic Cancer ◽  
Symptom Burden ◽  
Chinese Version ◽  
Chinese Patients ◽  
Gynecologic Cancers ◽  
Symptom Inventory ◽  
Md Anderson

Abstract Background: Gynecologic cancers are among the most prevalent malignancies in China, and millions of gynecologic cancer patients are expected to undergo open abdominal surgery as initial treatment. The tumor- and surgery-related symptom burden are not well studied owing to a lack of a standardized and validated assessment tool in Chinese. The study was to translate and validate the MD Anderson Symptom Inventory for measuring perioperative symptom burden in gynecologic cancer patients (MDASI-PeriOp-GYN) and examine the utility of the Chinese version.Methods: The MDASI-PeriOp-GYN was translated in a stepwise manner. First, two native speakers independently translated the 9 PeriOp-GYN symptom items. Then the 9 items were translated back into English by another two bilingual translators. After discussion and revision, the four translators reached an agreement. The finalized Chinese version was administered to women with three common gynecologic cancer types (cervical, ovarian, and endometrial cancers) recruited from the gynecological oncology department of Sichuan Cancer Hospital & Institute between July and October 2019. Reliability and validity of the translated version were assessed. Results: Overall, 324 women with gynecologic cancers were enrolled. Cronbach’s α values were 0.826 and 0.735 for the symptom severity and interference scales, respectively. Test-retest reliability values were 0.885, 0.873, and 0.914 for the symptom severity, PeriOp-GYN, and interference scales, respectively. Significant correlations were found between the MDASI-PeriOp-GYN-C and EORTC QLQ-C30 along with the QLQ-OV28 module (-0.608–0.871, P<0.001). Known-group validity was supported by significant differences in the scores of the four scales grouped by time intervals, surgery type, and functional status (all P<0.01). Conclusions: The MDASI-PeriOp-GYN-C is a valid and reliable tool for measuring symptoms in Chinese patients undergoing surgery for gynecologic cancers. The tool could be used in clinical practice and clinical trials to instantly gather patients’ health and quality of life data.

Development and Initial Validation of the Thyroid Cancer Module of the M. D. Anderson Symptom Inventory

Oncology ◽  
2008 ◽  
Vol 76 (1) ◽  
pp. 59-68 ◽  
Author(s):  
Ibrahima Gning ◽  
Peter C. Trask ◽  
Tito R. Mendoza ◽  
Margaret T. Harle ◽  
Karla A. Gutierrez ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Symptom Inventory ◽  
Initial Validation ◽  
Cancer Module

Reliability and validity of a Chinese version of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF-C)

2011 ◽  
Vol 20 (15-16) ◽  
pp. 2224-2232 ◽  
Author(s):  
Li-Chung Pien ◽  
Hsin Chu ◽  
Wen-Chun Chen ◽  
Yu-Shiun Chang ◽  
Yuan-Mei Liao ◽  
...  
Keyword(s):  
Short Form ◽  
Reliability And Validity ◽  
Chinese Version ◽  
Symptom Inventory

scholarly journals Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ting Zhang ◽  
Ying-ying Zheng ◽  
Zhi-rong Yang ◽  
Qiuling Shi ◽  
Xin Shelley Wang ◽  
...  
Keyword(s):  
Symptom Severity ◽  
Assessment Tool ◽  
Uterine Cancer ◽  
Gynecologic Cancer ◽  
Symptom Burden ◽  
Chinese Version ◽  
Chinese Patients ◽  
Gynecologic Cancers ◽  
Symptom Inventory ◽  
Md Anderson

Abstract Background Gynecologic cancers are among the most prevalent malignancies in China. Cervical and uterine cancer respectively account for the sixth and eighth highest incidence of cancer among Chinese women. Abdominal surgery is one of the important treatment methods for gynecological tumors. However, the tumor- and surgery-related symptom burden are not well studied owing to a lack of a standardized and validated assessment tool in the Chinese population. The study aimed to translate and validate the MD Anderson Symptom Inventory for measuring perioperative symptom burden in gynecologic cancer patients (MDASI-PeriOp-GYN) and examine the utility of the Chinese version of MDASI-PeriOp-GYN. Methods The MDASI-PeriOp-GYN was translated in a stepwise manner. First, two native speakers independently translated the 9 PeriOp-GYN symptom items. Then the nine items were translated back into English by two different bilingual translators. After discussion and revision, the four translators reached an agreement. Finally, the finalized Chinese version was administered to women with three common gynecologic cancer types (cervical, ovarian, and endometrial cancers) recruited from the gynecological oncology department of Sichuan Cancer Hospital & Institute between July and October 2019. The reliability and validity of the translated version were assessed. Results Overall, 324 women with gynecologic cancers were enrolled. Cronbach’s α values were 0.826 and 0.735 for the symptom severity and interference scales, respectively. Test–retest reliability values were 0.885, 0.873, and 0.914 for symptom severity, PeriOp-GYN, and interference scales. Significant correlations were found between the MDASI-PeriOp-GYN-C and EORTC QLQ-C30 along with the QLQ-OV28 module (− 0.608–0.871, P < 0.001). Known-group validity was supported by significant differences in the scores of the four scales grouped by time intervals, surgery type, and functional status (all P < 0.01). Conclusions The MDASI-PeriOp-GYN-C is a valid and reliable tool for measuring symptoms in Chinese patients undergoing surgery for gynecologic cancers. The tool could be used in clinical practice and clinical trials to instantly gather patients’ health and quality of life data.

scholarly journals Chinese version of the M. D. Anderson Symptom Inventory

Cancer ◽  
2004 ◽  
Vol 101 (8) ◽  
pp. 1890-1901 ◽  
Author(s):  
Xin Shelley Wang ◽  
Ying Wang ◽  
Hong Guo ◽  
Tito R. Mendoza ◽  
Xi-Shan Hao ◽  
...  
Keyword(s):  
Chinese Version ◽  
Symptom Inventory

Confirmatory Factor Analysis of the Chinese Version of the Pediatric Quality-of-Life Inventory Cancer Module

2013 ◽  
Vol 36 (6) ◽  
pp. E66-E72 ◽  
Author(s):  
Ho Cheung William Li ◽  
Phoebe D. Williams ◽  
Arthur R. Williams ◽  
Joyce O. K. Chung ◽  
Sau Ying Chiu ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Factor Analysis ◽  
Confirmatory Factor Analysis ◽  
Chinese Version ◽  
Quality Of Life Inventory ◽  
Cancer Module ◽  
Confirmatory Factor ◽  
Life Inventory
Sign in / Sign up

Export Citation Format

Share Document